Investor Relations

Financial Statements

Balance Sheets (Consolidated)

(Millions of yen)

Assets

  2021/3 2022/3 2023/3 2024/3 2025/3
Current assets 18,761 18,702 19,093 19,523 20,219
  Cash and deposits 4,677 4,445 5,532 4,647 5,732
  Notes and accounts receivable-trade 6,510 - - - -
  Notes and accounts receivable - trade, and contract assets - 9,518 8,939 8,566 7,224
  Electronically Recorded Monetary Claims Operating 1,567 1,767 1,695 2,012 2,562
  Completion construction account receivable 2,040 - - - -
  Merchandise and furnished goods 2,145 2,633 2,621 3,671 4,545
  Cost of uncompleted contracts 1,698 19 119 90 49
  Raw materials and supplies 7 10 8 7 5
  Others 113 308 177 529 99
  Allowance for doubtful accounts (0) (0) (0) (0) (0)
Noncurrent assets 12,694 12,684 12,826 13,044 13,039
  Property, plant and equipment 7,962 7,835 7,700 7,623 7,556
   Buildings and structures, net 1,814 1,705 1,623 1,536 1,426
   Machinery, equipment and vehicles, net 51 47 26 31 32
   Land 6,000 6,000 6,000 6,000 6,000
   Others 96 82 49 55 97
  Intangible assets 264 232 183 122 56
   Software 222 177 183 122 54
   Software In Progress 41 55 - - -
   Others 0 0 0 0 2
  Investments and other assets 4,467 4,616 4,943 5,298 5,426
   Investment securities 3,200 3,308 3,479 3,967 4,218
   Retirement benefit asset 1 42 35 30 11
   Deferred tax assets 176 117 148 82 82
   Insurance fund 920 982 1,126 1,071 967
   Others 176 174 161 154 153
   Allowance for doubtful accounts (7) (7) (7) (7) (7)
Total assets 31,455 31,387 31,920 32,568 33,259

Liabilities

  2021/3 2022/3 2023/3 2024/3 2025/3
Current liabilities 10,159 8,622 8,667 8,244 8,518
  Notes and accounts payable-trade 3,282 3,169 2,565 2,565 3,113
  Electronically Recorded Obligations Operating 676 1,471 1,493 1,939 1,615
  Construction unpaid money 391 544 199 178 212
  Short-term loans payable 1,830 1,690 2,100 1,600 1,650
  Current portion of long-term loans payable 834 440 490 521 190
  Income taxes payable 549 420 597 408 507
  Advances received on uncompleted construction contracts 1,358 - - - -
  Contract liabilities - 123 139 268 56
  Provision for bonuses 325 310 353 332 417
  Provision for loss on construction contracts 47 3 121 8 27
  Provision for special investigation expenses 221 - - - -
  Others 643 450 607 421 727
Noncurrent liabilities 3,627 3,607 3,152 2,872 2,878
  Long-term loans payable 2,992 2,904 2,414 2,092 2,174
  Deferred tax liabilities 309 355 312 368 336
  Provision for retirement benefits 30 24 29 17 -
  Provision for directors" share-based compensation 75 95 177 165 160
  Others 220 227 219 227 207
Total liabilities 13,787 12,230 11,820 11,117 11,397

Net assets

  2021/3 2022/3 2023/3 2024/3 2025/3
Shareholders" equity 17,465 19,000 19,901 21,098 21,494
  Capital stock 2,076 2,076 2,076 2,076 2,076
  Capital surplus 2,373 1,837 1,837 1,837 1,835
  Retained earnings 14,027 15,269 16,689 17,835 18,226
  Treasury stock (1,012) (183) (702) (651) (643)
Accumulated other comprehensive income 203 156 199 352 367
  Valuation differences on available-for-sale securities 190 166 201 349 377
  Deferred gains or losses on hedges 12 (10) (2) 3 (9)
Total net assets 17,668 19,156 20,100 21,450 21,861
Total liabilities and net assets 31,455 31,387 31,920 32,568 33,259

Statements of Income (Consolidated)

(Millions of yen)

  2021/3 2022/3 2023/3 2024/3 2025/3
Net sales 26,727 31,329 29,656 27,916 26,568
Cost of sales 20,688 24,808 22,650 21,295 19,715
Gross profit 6,039 6,520 7,006 6,620 6,853
Selling, general and administrative expenses 3,848 3,969 4,152 4,123 4,321
Operating income 2,190 2,551 2,853 2,497 2,532
Non-operating income 243 306 191 371 393
 Interest income 26 26 31 40 39
 Equity in earnings of affiliates 183 205 130 295 254
 Money of insurance return 8 47 - 1 52
 Others 25 26 29 34 46
Non-operating expenses 40 45 61 52 83
 Interest expenses 28 26 24 21 27
 Insurance cancellation of a contract loss 2 13 19 27 50
 Compensation for damage - - 7 - -
 Others 9 4 8 4 5
Ordinary income 2,393 2,812 2,984 2,816 2,842
Extraordinary income - 70 - 33 48
 Gain on sales of noncurrent assets - - - - 0
 Investment securities sale gain - 70 - 33 46
 Others - - - - 1
Extraordinary loss 223 2 0 7 0
 Loss on sales of noncurrent assets 1 - - - 0
 Loss on retirement of noncurrent assets 0 0 0 2 -
 Investment securities sale loss - - - - -
 Loss On Valuation Of Investment Securities - 1 - 4 -
 Provision for special investigation expenses 221 - - - -
Income before income taxes 2,170 2,880 2,984 2,842 2,890
Income taxes-current 706 736 961 793 850
Income taxes-deferred (80) 130 (92) 50 (39)
Total income taxes 626 866 869 844 811
Income before minority interests 1,544 2,014 2,114 1,997 2,079
Minority interest - - - - -
Net income 1,544 2,014 2,114 1,997 2,079

Statements of Cash Flows (Consolidated)

(Millions of yen)

  2021/3 2022/3 2023/3 2024/3 2025/3
Net cash provided by (used in) operating activities          
 Income before income taxes 2,170 2,880 2,984 2,842 2,890
 Depreciation and amortization 244 249 240 224 251
 Special investigation expenses, etc. 221 - - - -
 Increase (decrease) in debt for retirement benefits (30) (5) 5 (11) (17)
 Increase (decrease) in provision for bonuses (14) (15) 42 (20) 84
 Increase (decrease) in provision for loss on construction contracts (15) (43) 117 (113) 19
 Interest and dividends income (26) (26) (31) (40) (39)
 Loss (gain) on cancellation of insurance policies (6) (33) 19 26 (2)
 Interest expenses 28 26 24 21 27
 Investment profit and loss by the equity method (183) (205) (130) (295) (254)
 Loss (gain) on sales and retirement of noncurrent assets 1 1 0 2 0
 Loss (gain) on valuation of investment securities - 1 - 4 -
 Loss (gain) on sales of investment securities - (70) - (33) (46)
 Decrease (increase) in notes and accounts receivable-trade (852) - - - -
 Decrease (increase) in trade receivables and contract assets - (1,167) 651 55 792
 Decrease (increase) in inventories 522 1,188 (87) (1,019) (832)
 Decrease (increase) in account receivable - other 2 17 (27) 25 (2)
 Decrease (increase) in consumption taxes refund receivable - - 29 (300) 300
 Increase (decrease) in notes and accounts payable-trade (705) 835 (926) 414 257
 Increase (decrease) in account payable - other (133) (75) (9) (22) 6
  Increase (Decrease) In Advances Received (47) - - - -
 Increase (decrease) in Construction acceptance money 203 - - - -
 Increase (decrease) in contract liabilities - (1,304) 15 129 (211)
 Others 122 (267) 331 (154) 269
 Subtotal 1,502 1,984 3,251 1,734 3,494
 Interest and dividends income received 37 36 41 49 51
 Interest expenses paid (28) (25) (24) (20) (28)
 Insurance income received 6 11 4 4 11
 Compensation for damage paid - - (7) (0) -
 Payments of special investigation expenses, etc. - (221) - - -
 Loss on disaster paid - - - - -
 Income taxes refund(paid) (630) (898) (726) (1,049) (684)
 Net cash provided by (used in) operating activities 887 886 2,538 717 2,844
Net cash provided by (used in) investing activities          
 Purchase of property, plant and equipment (100) (39) (22) (47) (46)
 Proceeds from sales of property, plant and equipment 5 - - - -
 Purchase of intangible assets (93) (26) (17) (10) (5)
 Gain on redemption of investment securities - 120 - 45 82
 Purchase of insurance funds (262) (276) (338) (264) (246)
 Proceeds from maturity of insurance funds 36 215 176 298 357
 Others (1) (0) (4) 4 0
 Net cash provided by (used in) investing activities (415) (5) (206) 25 140
Net cash provided by (used in) financing activities          
 Net increase (decrease) in short-term loans payable 700 (140) 410 (500) 50
 Proceeds from long-term loans payable 300 - - 200 -
 Repayment of long-term loans payable (605) (482) (440) (490) (248)
 Expenses by the merit of the treasury stock (0) - (521) (0) (940)
 The income by the disposal of a treasury stock - - - 28 26
 Cash dividends paid (455) (479) (695) (851) (780)
 Others (12) (11) 0 (13) (6)
 Net cash provided by (used in) financing activities (73) (1,113) (1,245) (1,626) (1,899)
Effect of exchange rate change on cash and cash equivalents (0) 1 (0) 0 (0)
Net increase (decrease) in cash and cash equivalents 397 (231) 1,086 (883) 1,085
Cash and cash equivalents at beginning of period 4,278 4,675 4,443 5,530 4,647
Cash and cash equivalents at end of period 4,675 4,443 5,530 4,647 5,732

Back to Top